Journal
JOURNAL OF MOLECULAR ENDOCRINOLOGY
Volume 42, Issue 3-4, Pages 269-282Publisher
BIOSCIENTIFICA LTD
DOI: 10.1677/JME-08-0142
Keywords
-
Categories
Funding
- Medical Research Council [G108/502, G0501486]
- Wellcome Trust [GR076584]
- BBSRC [BB/F021704/1] Funding Source: UKRI
- MRC [G108/502, G0501486, G0800261] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/F021704/1] Funding Source: researchfish
- Medical Research Council [G0800261] Funding Source: researchfish
Ask authors/readers for more resources
Analysis of mice harbouring deletions or mutations of T(3) receptor alpha (TR alpha) and beta (TR beta) have clarified the complex relationship between central and peripheral thyroid status and emphasised the essential but contrasting roles of T(3) in skeletal development and adult bone. These studies indicate that TR alpha 1 is the predominant TR expressed in bone and that T(3) exerts anabolic actions during growth but catabolic actions in the adult skeleton. Examination of key skeletal regulatory pathways in TR mutant mice has identified GH, IGF-1 and fibroblast growth factor signalling and the Indian hedgehog/parathyroid hormone-related peptide feedback loop as major targets of T(3) action in chondrocytes and osteoblasts. Nevertheless, although increased osteoclastic resorption is a major feature of thyrotoxic bone loss and altered osteoclast activity is central to the skeletal phenotype of TR mutant mice, it remains unclear whether T(3) has direct actions in osteoclasts. Detailed future analysis of the molecular mechanisms of T(3) action in bone will enhance our understanding of this emerging field and has the potential to identify novel strategies for the prevention and treatment of osteoporosis. Journal of Molecular Endocrinology (2009) 42, 269-282
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available